23 October 2021>: Clinical Research
Repetitive Transcranial Magnetic Stimulation (rTMS) Modulates Thyroid Hormones Level and Cognition in the Recovery Stage of Stroke Patients with Cognitive Dysfunction
Hong Li 1AE* , Jiang Ma 1AE** , Jun Zhang 2C , Wan-Ying Shi 3F , Hao-Nan Mei 2B , Yan Xing 1CDOI: 10.12659/MSM.931914
Med Sci Monit 2021; 27:e931914
Table 6 Comparison of post-treatment change (post-test–pre-test) in thyroid hormones and TSH levels in the 2 groups.
Group | T3 (nmol/L) | T4 (nmol/L) | FT3 (pmol/L) | FT4 (pmol/L) | TSH (uIU/mL) |
---|---|---|---|---|---|
rTMS (n=33) | 0.21 (0.10, 0.36) | −0.92 (−16.47, 18.40) | 0.57 (0.07, 1.04) | −0.40 (−1.62, 0.60) | 0.98 (0.29, 1.55) |
Sham (n=32) | 0.11 (−0.07, 0.11) | −9.63 (−18.22, 1.25) | 0.08 (−0.09, 0.43) | −1.00 (−2.36, 0.92) | 0.07 (−0.17, 0.47) |
U | −2.324 | −1.319 | −2.625 | −0.761 | −3.438 |
P | 0.020 | 0.187 | 0.009 | 0.447 | 0.001 |
Data presented as median (P25, P75). rTMS – repetitive transcranial magnetic stimulation. |